预防结核病后后果的干预措施:系统审查和元分析
Kefyalew Addis Alene1,2,3, Lucas Hertzog1, Beth Gilmour1,2
1School of Population Health, Faculty of Health Sciences, Curtin University, Australia.
EClinicalMedicine
|March 4, 2024
概括
康复计划有效地预防结核病 (TB) 后的肺部,神经和精神健康问题. 对于其他干预措施来管理长期的结核病健康问题,需要进一步的研究.
科学领域:
- 公共卫生 公共卫生
- 传染性疾病 传染性疾病
- 临床医学 临床医学
背景情况:
- 结核病 (TB) 构成了严重的全球健康负担,导致死亡率和发病率.
- 结核病幸存者经常经历长期的健康问题,称为后结核病后果.
- 目前用于治疗结核病后病情的策略受到证据不足的限制.
研究的目的:
- 系统地审查和分析旨在预防结核病后后果的干预措施.
- 确定有效的策略,以改善结核病幸存者的健康结果.
主要方法:
- 我们对PubMed,SCOPUS,Web of Science和Cochrane图书馆进行了系统的搜索.
- 包括有关旨在预防结核病后后果的干预措施的报告研究.
- 进行了一项随机效应元分析,使用I2统计数据评估异质性.
主要成果:
- 康复计划显示出显著的益处,改善肺功能和预防神经系统的后果.
- 综合干预和认知行为疗法有效降低了精神健康障碍的风险.
- 针对结核病后肝脏病情的干预措施和针对神经病情的辅助疗法没有显著的预防作用.
结论:
- 康复计划是有效的预防肺部,神经和心理健康后果结核病.
- 辅助疗法和其他干预措施需要进一步研究预防结核病后并发症的有效性.
相关概念视频
Pulmonary Tuberculosis V
179
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
179
Pulmonary Tuberculosis IV
142
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
142
Pulmonary Tuberculosis I
242
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
242
Pulmonary Tuberculosis II
236
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
236
Pulmonary Tuberculosis III
325
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
325
Pneumothorax-II
145
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
145


